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 Role of Radiologic Imaging 
in Irritable Bowel Syndrome: 
 Evidence-based Review 1 
 Owen J.  O’Connor ,  MD 
 Sean E.  McSweeney ,  MB 
 Sebastian  McWilliams ,  MB 
 Siobhan  O’Neill ,  MB 
 Fergus  Shanahan ,  MD 
 Eamonn M. M.  Quigley ,  MB 
 Michael M.  Maher ,  MD 
 Purpose: To critically evaluate the current literature in an effort to establish 
the current role of radiologic imaging (computed tomography, 
magnetic resonance imaging, ultrasonography [US], fl uoroscopy, 
conventional fi lm radiography) in irritable bowel syndrome (IBS).
 Materials and 
Methods: 
The term “irritable bowel syndrome ” was used to search Clini-
cal Evidence, UpToDate, Cochrane Library, TRIP, and National 
Institute for Health and Clinical Excellence databases and the 
 American College of Physicians Journal Club and  Evidence-
Based Medicine online. PubMed was searched by using medical 
subject headings (“irritable bowel syndrome;” “colonic diseases, 
functional;” “diagnosis;” “colonography; ” “computed tomo-
graphic (CT)”) and the dates January 1, 1985 to July 1, 2010. 
Appraisal was independently performed by two reviewers who 
followed the Oxford Centre for Evidence Based Medicine prac-
tice criteria.
 Results: No systematic review (SR) specifi cally examined radiologic im-
aging in IBS; however, in the secondary literature, fi ve relevant 
SRs or guidelines partially addressed this topic. A PubMed 
search identifi ed 1451 articles, 111 of which at least partially ad-
dressed radiologic imaging. Of these, seven valid articles (two 
SRs and fi ve primary research articles) were identifi ed. The fi ve 
primary research articles examined either colonic investigations 
(colonoscopy and barium enema examination) ( n = 5) or US 
( n = 2) or both ( n = 2). Structural disease found infrequently in 
patients with IBS-type symptoms included diverticulosis, colo-
rectal cancer, celiac disease, infl ammatory bowel disease, and 
ovarian cancer. The incidence of structural disease in patients 
with concerning symptoms was low.
 Conclusion: Although widely used, there is a surprising paucity of evidence 
guiding radiologic imaging in IBS. Radiologic imaging may not 
be required in patients with IBS without potentially concern-
ing symptoms but should be considered where such symptoms 
exist, and choice of imaging study should be infl uenced by pre-
dominant symptoms. Defi nitive recommendations must await 
further research.
 q RSNA, 2011 1 From the Departments of Radiology (O.J.O., S.E.M., 
S.M., S.O., M.M.M.) and Medicine (Gastroenterology) 
(F.S., E.M.M.Q.), Cork University Hospital and Alimentary 
Pharmabiotic Centre, University College Cork, Wilton, Cork, 
Ireland. Received February 23, 2011; revision requested 
April 19; revision received July 29; accepted August 26; 
fi nal version accepted September 6.  Address correspon-
dence to M.M.M. (e-mail:  M.Maher @ucc.ie ). 
 q RSNA, 2011 
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practice accounts for a considerable 
portion of the economic burden asso-
ciated with IBS ( 2 ). With a prevalence 
of approximately 14%–24% in women 
and 5%–19% in men, IBS is responsible 
for 2.4–3.5 million physician visits per 
year in the United States at a cost of 
$1.6 million ( 2 ). 
 The purpose of this systematic re-
view (SR) was to critically evaluate the 
current literature in an effort to establish 
the current role of radiologic imaging 
(computed tomography [CT], magnetic 
resonance [MR] imaging, ultrasonog-
raphy [US], fl uoroscopy, conventional 
fi lm radiography) in IBS. An important 
step in attempting to answer the above 
question was to address the following 
issues: current recommendations guid-
ing radiologic imaging in IBS, radiologic 
imaging in patients with IBS without 
symptoms concerning for underlying 
structural disease, and radiologic imag-
ing in patients with IBS with symptoms 
concerning for underlying structural 
disease. 
 Materials and Methods 
 Literature Search 
 The literature was searched and ev-
idence was appraised independently 
by two reviewers, one (S.E.M.) with 
7 years of radiology experience and re-
cent completion of a 7-month course of 
radiologists, with a consequential lack 
of IBS-related research in the radiologic 
literature. On one hand, clinicians, mind-
ful of the nonspecifi c nature of gastro-
intestinal symptoms such as abdominal 
pain and discomfort and disturbed def-
ecation, fear missing something, while, 
on the other hand, unnecessary radio-
logic imaging is wasteful of resources 
and potentially exposes patients unnec-
essarily to ionizing radiation. Although 
no data exist on this issue, it is likely, 
given the reported prevalence of IBS, 
that considerable resources are expended 
on unnecessary radiologic imaging in 
patients with IBS. It has been shown 
that extensive diagnostic testing in pa-
tients meeting the symptom-based cri-
teria for IBS has a low pretest probabil-
ity of fi nding structural disease, and this 
 Irritable bowel syndrome (IBS) is a chronic gastrointestinal condition characterized by abdominal discom-
fort, bloating, and disturbed defecation 
( 1,2 ). Because IBS lacks characteristic 
imaging features and there are currently 
no diagnostic biomarkers, symptom-based 
criteria (Manning and Rome I–III) are 
recommended for diagnosis ( Table 1 ) 
( 3–6 ). The Rome III (2006) criteria, for 
example, were reported to have a sen-
sitivity of 70% and a specifi city of 90% 
for IBS in a study of 328 patients with a 
clinical diagnosis of IBS ( 7 ). 
 In clinical practice, however, ra-
diologic imaging is performed in many 
patients with IBS, particularly in those 
with so-called alarm symptoms ( Table 2 ) 
(ie , symptoms concerning for underly-
ing structural disease, which might be 
misclassifi ed as IBS [ 9 ]). There is a pau-
city of information regarding the ap-
propriate use of abdominal imaging in 
patients with IBS, and few studies have 
investigated typical diagnostic yields in 
this setting ( 10 ). As a result, the role 
of radiologic imaging in IBS is poorly 
defi ned, and there appears to be a lack of 
clinical or research interest in IBS among 
 Implications for Patient Care 
 On the basis of current, albeit  n
limited, best evidence, we con-
clude that patients fulfi lling the 
symptom-based diagnostic crite-
ria for IBS and who do not ex-
hibit concurrent potentially wor-
risome symptoms such as blood 
in stool, weight loss, recurrent 
fevers, anemia, and chronic 
severe diarrhea and who have no 
family history of colorectal 
cancer, infl ammatory bowel 
disease, or celiac sprue do not 
require radiologic imaging. 
 Current evidence suggests that  n
radiologic imaging is required in 
patients with concerning symp-
toms who fulfi ll the symptom-
based diagnostic criteria for IBS. 
 Optimal radiologic imaging of the  n
patient with IBS should be 
guided by the likely alternative 
diagnosis and adherence to the 
relevant American College of Ra-
diology Appropriateness Criteria. 
 Endoscopy appears more suitable  n
than radiologic imaging for co-
lonic investigation of patients 
with diarrhea-predominant and 
mixed-type IBS owing to the re-
quirement to exclude micro-
scopic or lymphocytic colitis by 
using biopsy. 
 Advances in Knowledge 
 The current evidence guiding the  n
performance of radiologic im-
aging in patients with irritable 
bowel syndrome (IBS) is insuffi -
cient; no systematic review (SR) 
focusing solely on IBS exists in 
the literature, and further study 
is therefore required. 
 The incidence of structural  n
disease appears to be low in 
patients with IBS who do not 
have concerning symptoms; po-
tentially concerning symptoms 
such as blood in stool, weight 
loss, recurrent fevers, anemia, 
and chronic severe diarrhea and 
family history of colorectal 
cancer, infl ammatory bowel 
disease, or celiac sprue are poor 
discriminators for the presence 
of structural disease but should 
prompt further investigation, 
pending the generation of more 
robust evidence. 
 Published online before print 
 10.1148/radiol.11110423 Content code:  
Radiology 2012; 262:485–494
 Abbreviations: 
 IBS = irritable bowel syndrome 
 SR = systematic review 
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systems and the primary literature 
(journals), which were examined from 
the top down ( 11 ). 
 Secondary Literature Search 
 The search that formed the basis of 
this SR initially focused on the second-
ary literature (evidence-based reviews, 
syntheses, or guidelines that follow 
evidence-based practice methods) ( 11 ). 
Initially, the broad search term “irrita-
ble bowel syndrome” was deliberately 
chosen to achieve a high sensitivity in 
the search for relevant SRs. Databases 
considered to be at the top of the evi-
dence pyramid, namely Clinical Evidence 
and UpToDate, were initially searched 
( 11 ). The next level searched included 
the Cochrane Library, the TRIP data-
base, and the National Institute for 
Health and Clinical Excellence databases. 
After this, a search of the  American 
College of Physicians Journal Club and 
 Evidence-Based Medicine online was 
performed. 
 Primary Literature Search 
 Finally, a primary literature search 
by using the United States National 
Library of Medicine’s PubMed  (www
.pubmed.gov) search engine was per-
formed. Search terms were chosen on 
the basis of the PICO question and prior 
SRs of IBS ( 10,14–18 ). Medical sub-
ject headings (MeSH) and free text 
terms were searched for the terms 
“irritable bowel syndrome”[MeSH] OR 
“colonic diseases, functional”[MeSH ] 
AND “diagnosis”[MeSH]. Subsequently, 
a separate PubMed search using the 
terms “irritable bowel syndrome”[MeSH] 
AND “colonography, computed tomo-
graphic (CT)”[MeSH] was performed 
to identify articles that investigated 
the role of CT colonography in pa-
tients with IBS. The search was limited 
to “1985/01/01”[PDAT] to “2010/07/
01”[PDAT] AND English [language] 
AND humans. 
 Appraisal 
 Abstracts of articles retrieved from the 
primary and secondary literature were 
reviewed to identify articles that re-
ported  (a) current recommendations 
guiding radiologic imaging in IBS and 
described previously in radiology liter-
ature ( 11–13 ). 
 Focused Clinical Question 
 The PICO (patient, intervention, com-
parison intervention, and outcomes 
of interest) format of evidence-based 
question formulation was used. The 
PICO question utilized for this SR was 
written in text form as follows: “In pa-
tients with IBS, how does radiological 
imaging compare with symptom-based 
diagnosis for the detection of struc-
tural pathology or an alternative di-
agnosis.” To answer this question, an 
evidence-based practice paradigm was 
followed; the literature was viewed as 
an evidence pyramid consisting of four 
levels: secondary evidence composed of 
syntheses, synopses, and information 
instruction in evidence-based medicine. 
The second reviewer (M.M.M.) had 
15 years of radiology experience and 
was an instructor in evidence-based 
practice with 10 years of experience 
in evidence-based medicine. Discrep-
ancies were reviewed and resolved by 
a third reviewer (E.M.M.Q., with 30 
years of experience in internal med-
icine) who coauthored several consen-
sus statements and SRs of IBS. Twenty-
fi ve articles were reviewed by the third 
reviewer. The literature search was 
commenced in 2008 and was repeated 
on several occasions until January 
2011. This SR was performed by pos-
ing an answerable question, searching 
and appraising the available evidence 
and applying the fi ndings, and using 
evidence-based medicine practices as 
 Table 1 
 Symptom-based Criteria for the Diagnosis of IBS 
Parameter Criteria
Manning Abdominal pain relieved by defecation; looser stools with the onset of pain; more 
  frequent stools with the onset of pain; abdominal distention; passage of mucous; 
incomplete defecation
Rome At least 12 weeks of continuous or recurrent symptoms; abdominal pain or discomfort 
  relieved with defecation, associated with change in frequency or consistency of 
stool; two or more of the following: altered stool frequency, form, or passage or 
passage of mucous or bloating or abdominal distention
Rome II At least 12 weeks, which need not be consecutive, in preceding 12 months of abdominal 
  discomfort or pain associated with two of three features: relieved by defecation 
and/or change in frequency of stool and/or change in form (appearance of stool)
Rome III Recurrent abdominal pain or discomfort at least 3 days a month in past 3 months 
  associated with two of three of the following: improvement with defecation and/or 
change in frequency of stool and/or change in form (appearance of stool)
 Table 2 
 Symptoms Concerning for Structural Cause of Abdominal Symptoms in Patients 
with IBS 
Symptom of Potential Concern Frequency * Sensitivity (%) † 
Blood in stool 210/1425 (14.7) 22.0
Awakened by gastrointestinal symptoms 565/1431 (39.5) 52.4
Unintended weight loss 325/1420 (22.9) 36.6
Antibiotic use 476/1411 (33.7) 40.7
Colon cancer family history 250/1426 (17.5) 26.8
Symptom onset after age 50 506/1411 (35.9) 47.6
Source.—Reference  8 .
* Data are ratios of patients, with percentages in parentheses.
 † Reported sensitivity is for the detection of gastrointestinal cancer, infl ammatory bowel disease, or malabsorption.
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only partially examined radiologic im-
aging in IBS, and the two studies that 
focused solely ( 31,32 ) on radiologic 
imaging were lower quality case series 
(grade 4) and studied either barium 
enema or US. One study included in-
complete radiologic imaging data in the 
setting of IBS ( 28 ). Unfortunately, the 
diagnostic yield of radiologic imaging 
was not detailed by Vanner et al ( 28 ) 
for the 11 of 30 patients with IBS who 
underwent barium enema prior to en-
rollment. In addition, 24% (23 of 95) 
of patients underwent US prior to re-
ferral to a gastroenterology clinic; pre-
sumably, these investigations would 
have excluded a number of other pa-
tients from the study. Fifty-eight of 95 
patients fulfi lling the Rome criteria and 
lacking concerning symptoms for struc-
tural disease underwent either barium 
enema or colonoscopy; however, the 
proportion of barium enema exami-
nations performed and the fi ndings of 
these studies were not reported ( 28 ). 
The yield of radiologic imaging in pa-
tients who were subsequently found not 
to have IBS was not provided. Treacher 
et al ( 31 ), which was published in 1986, 
exclusively studied radiologic imaging 
(barium enema) in IBS and did not use 
any specifi c criteria for the diagnosis of 
IBS. In this retrospective study, patients 
had a clinical diagnosis of IBS at a fi rst 
clinic visit after review by a physician 
in training or an attending gastroen-
terologist. Patients were excluded if 
there was a history of weight loss or 
blood per rectum; there was no control 
group, and all patients underwent sig-
moidoscopy. An article by Francis et al 
( 32 ) investigated radiologic imaging 
(US) in IBS and studied patients who 
fulfi lled the Rome criteria for IBS, af-
ter excluding those with abnormal he-
matologic and biochemistry fi ndings or 
who had frank or occult blood detected 
at stool examination. Because US was 
used for radiologic imaging, the bowel 
could not be examined, and all patients 
required sigmoidoscopy ( 32 ). On the 
other hand, an article by Tolliver et al 
( 30 ) studied the yield of biochemical, 
hematologic, and lactose hydrogen 
breath testing and structural imaging in 
patients meeting the clinical criteria for 
articles (one SR [ 2 ] from the TRIP da-
tabase and three evidence-based guide-
lines from the National Institute for 
Health and Clinical Excellence database 
[ 23,24 ] and from the TRIP database 
[ 25 ]). These reviews or guidelines com-
prehensively investigated many aspects 
of diagnosis and management of IBS in-
cluding some analysis of radiologic im-
aging, although their primary focus was 
not imaging. These fi ve articles were se-
lected as representing the current best 
evidence regarding radiologic imaging 
in IBS. 
 Primary Literature Search 
 The PubMed search yielded 1451 stud-
ies, 111 of which were potentially rel-
evant after abstract review ( 26 ). The 
1340 articles excluded referred to some 
aspect of IBS, but on review of the arti-
cle’s abstract, there was no reference to 
the issue of radiologic imaging in IBS. 
Review of the short-listed articles ( n = 
111), supplemented, where necessary, 
by review of full-text versions, identi-
fi ed two additional SRs ( 10,27 ), both 
of which included Brandt as an author; 
the second SR published in 2009 was 
considered more valid to the current 
SR. In addition, fi ve valid primary re-
search articles ( 28–32 ) were identifi ed, 
in which there was some focus on the 
issue of radiologic imaging in IBS. IBS 
was diagnosed by using symptom-based 
criteria in all but one article (Manning, 
Rome, or modifi ed Rome criteria). 
These articles studied radiologic inves-
tigation of patients with IBS to a var-
iable extent ( Table 3 ). Five articles at 
least partially studied radiologic investi-
gations in IBS (barium enema examina-
tion, US). Only two studies specifi cally 
addressed the role of radiologic imaging 
in IBS ( 31,32 ): barium enema examina-
tion exclusively in one ( 31 ) and US in 
another ( 32 ). 
 Grading of the levels of evidence 
and recommendation of these studies 
by using evidence-based practice criteria 
is summarized in  Table 4 . The quality 
of the methods of the retrieved stud-
ies was either moderate or low (grade 
2B–4). Unfortunately, the articles with 
moderate quality evidence-based practice 
grading (retrospective cohort studies) 
 (b) radiologic imaging in patients with 
IBS with and without concerning symp-
toms. Full-text versions of the highest 
level articles (graded by following evi-
dence-based practice diagnosis and SR 
criteria described by the Oxford Centre 
for Evidence Based Medicine  [http://www
.cebm.net/index.aspx?o=1157] ) were 
reviewed to select those that were the 
most specifi c and comprehensive and 
used the best methods available with 
homogeneous disease classifi cation and 
terminology. 
 Data Extraction and Analysis 
 For studies that investigated radiologic 
imaging in patients with IBS symptoms, 
data extracted included  (a) the popu-
lation studied, including the propor-
tion of female patients,  (b) the type of 
symptom-based criteria used (Manning 
[ 3 ], Rome I, II, or III [ 4–6 ], American 
College of Gastroenterology [ 10 ], World 
Gastroenterology Organization [ 12 ]), 
 (c)  the type of intervention (diagnos-
tic evaluation performed and reference 
standard comparison, if applied),  (d) 
outcomes (prevalence of confi rmed 
structural gastrointestinal disease, re-
sulting in an alternative diagnosis), and 
 (e) statistical analyses pertaining to the 
accuracy of radiologic imaging tests, 
including sensitivity, specifi city, posi-
tive predictive and negative predictive 
values, confi dence intervals, positive 
likelihood ratio, and negative likelihood 
ratio ( 2,7,12,13,19,20 ). These statisti-
cal analyses were performed by using 
the online KT Clearinghouse Statistics 
Calculator funded by the Canadian In-
stitute for Health Research ( 21 ). 
 Results 
 Secondary Literature Search 
 No SR focused solely on the use of ra-
diologic imaging in IBS was found. The 
highest level of evidence in the second-
ary literature (UpToDate) contained one 
article; that article did not focus solely 
on the role of radiologic imaging in IBS 
but discussed imaging among other 
issues in IBS ( 22 ). Searches of lower 
levels of evidence in the secondary lit-
erature yielded four additional relevant 
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only 27% (seven of 26) of patients with 
indicators of structural disease actually 
had a structural abnormality identifi ed. 
Again, although imaging was used to 
evaluate some patients, no data were 
presented specifi cally referring to radio-
logic imaging. Four of the articles in the 
primary literature ( 28,30–32 ) examined 
200 or fewer patients with IBS, which is 
a relatively small number for a common 
disorder of considerable heterogeneity. 
Only one article reported suffi cient data 
pertaining to radiologic imaging to al-
low statistical analysis ( Table 5 ). The 
results reported by Treacher et al ( 31 ) 
suggest that US has a sensitivity of 96% 
and specifi city of 95% for the detection 
of a structural abnormality in patients 
with IBS. No primary literature article 
studied CT, which would be most likely 
to offer the best one-stop imaging ex-
amination of the abdomen. The fl aws, 
listed previously, which affect all of the 
articles in different ways, detracted 
from the strength of the conclusions or 
recommendations that could be drawn 
in this review. 
 Current recommendations guiding 
radiologic imaging in IBS.— Radiologic 
imaging in patients with IBS was dis-
cussed in part by guidelines written by the 
American College of Gastroenterology 
task force ( 27 ). This task force recom-
mended that for diarrhea-predominant 
IBS, “it is appealing to suggest that 
IBS-type symptoms, but the proportion 
of patients who required imaging, the 
type of imaging, and their results were 
not documented ( 29 ). Treacher et al 
( 31 ) noted that 27% (nine of 34) of 
patients with structural disease had an 
indicator of underlying disease and that 
IBS. The selection criteria used in this 
article therefore would suggest that a 
different patient cohort was examined 
than that in the article by Francis et al 
( 32 ). Only one article quantifi ed the 
effect of concerning symptoms on the 
diagnosis of disease in patients with 
 Table 3 
 Summary of Research Articles Found in Primary Literature 
Diagnostic Test and Author No. of Patients
No. of Control 
Subjects Age (y) * Female Patients (%)
Prevalence of Structural 
Disease † 
Prevalence of Structural 
Disease in Control Subjects
Colonic ‡ 
 Vanner et al ( 28 ) 193 0 17–89 86 NA NA
 Hamm et al ( 29 ) 1452 0 45 71 2 (7/306) NA
 Tolliver et al ( 30 ) 196 0 44 81 21.9 (43/196) NA
 Treacher et al ( 31 ) 114 0 48 70 23 (26/114) NA
 Francis et al ( 32 ) 125 0 39 80 18 (23/125) NA
US
 Vanner et al ( 28 ) 193 0 17–89 86 NA NA
 Francis et al ( 32 ) 125 0 39 80 18 (23/125) NA
Note.—NA = not available.
* Data are means or ranges.
 † Data are percentages, with numbers used to calculate percentages in parentheses.
 ‡ Colonic investigations included conventional colonoscopy, sigmoidoscopy, and barium enema examination.
 Table 4 




Includes Data Specifi c 
to Diagnostic Imaging
Focused on Diagnostic 
Imaging
Vanner et al ( 28 ) 2B No No
Hamm et al ( 29 ) 2B No No
Tolliver et al ( 30 ) 2B No No
Treacher et al ( 31 ) 4 Yes Yes
Francis et al ( 32 ) 4 Yes Yes
 Table 5 
 Statistical Analysis of Results in One Article on the Use of US in Patients with Clinical 
Diagnosis of IBS 
Parameter Datum Confi dence Interval
Sensitivity (%) 96 72, 99
Specifi city (%) 95 88, 98
Positive predictive value (%) 78 54, 92
Negative predictive value (%) 99 94, 99
Positive likelihood ratio 20.33 7.3, 56.9
Negative likelihood ratio 0.04 0.003, 0.612
Source.—Reference  31 .
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conventional fi lm radiography in IBS 
were found. 
 Radiologic imaging in patients with 
IBS without symptoms concerning for 
underlying structural disease.— The 
American College of Gastroenterology 
task force analyzed the performance 
of colonic imaging in patients with IBS 
without symptoms to suggest underlying 
structural disease and referenced a SR 
that included three studies incorporat-
ing 636 patients with IBS who under-
went colonoscopy or barium enema, 
with or without fl exible sigmoidoscopy 
( 27 ). Structural disease was found in 
only 1.3% (eight of 636) of patients 
(95% confi dence interval: 0.06%, 2.3%) 
( Table 6 ) ( 27 ). The incidence of many 
structural diseases, such as infl amma-
tory bowel disease, colorectal cancer, 
and gastrointestinal infection, was very 
low in patients with IBS and compara-
ble with that of the general population; 
the prevalence of celiac disease and lac-
tose intolerance, in contrast, seemed to 
be slightly higher in the IBS population 
( 27 ). The American College of Gastro-
enterology task force also referenced an 
interim analysis of a prospective con-
trolled multicenter trial conducted in the 
United States that compared colonos-
copy in 216 patients with diarrhea-pre-
dominant IBS or mixed diarrhea and 
constipation–type IBS with 416 control 
subjects undergoing screening for colo-
rectal cancer and found no difference 
in the prevalence of colorectal cancer 
between patients with IBS and control 
subjects (IBS, 0% [0 of 216]; control 
subjects, 0.2% [one of 416]) or that of 
infl ammatory bowel disease (IBS, 0.46% 
[one of 216]; control subjects, 0% [0 of 
416]) ( 17 ). Interestingly, the prevalence 
of adenomatous polyps (14% [30 of 
216] vs 26% [109 of 416],  P = .0004) 
and diverticulosis (13% [28 of 216] vs 
21% [88 of 416],  P = .01) were lower 
in the IBS cohort than in the patients 
undergoing screening investigations for 
colorectal cancer ( 27 ). Therefore, the 
American College of Gastroenterology 
SR concluded that colonic imaging was 
not required routinely in patients with 
IBS who were younger than 50 years in 
the absence of symptoms suggestive of 
underlying structural disease. 
necessarily symptoms concerning for 
underlying structural disease. Struc-
tural disease was found in 12 patients 
(84 underwent barium enema), includ-
ing uncomplicated diverticular disease 
and polyps but no cancer or infl amma-
tory bowel disease ( 31 ). Patients with 
positive fi ndings had biochemical or 
hematologic abnormalities that would 
have merited further examination. A 
prospective study of 1452 patients with 
IBS, irrespective of the presence of 
symptoms concerning for underlying 
structural disease, identifi ed colonic 
disease in 2% (seven of 306) after 
colonoscopy or sigmoidoscopy with 
barium enema ( 29 ). Diagnostic imaging 
depicted an alternative cause for ab-
dominal pain in four of these seven pa-
tients. Therefore, it was concluded that 
the low yield, cost, and inconvenience 
of diagnostic investigations should pre-
cipitate reevaluation of investigation 
patterns ( 29 ). 
 Routine US in patients with IBS is 
currently not indicated on the basis 
of the only primary literature article 
on this topic ( 32 ). Pathologic fi ndings 
were found by using US in 22 of 125 
patients (20 of 100 female patients and 
two of 25 male patients) with a diagno-
sis of IBS by using Rome I criteria ( 32 ). 
Gallstones, benign liver abnormalities, 
uterine fi broids, and adnexal cysts were 
found in female patients, and gallstones 
and hepatic steatosis were found in 
male patients. None of these abnormal-
ities resulted in additional therapy. He-
patobiliary abnormalities were found in 
similar proportions of male and female 
patients (10% [10 of 100] vs 8% [two 
of 25]). Although gallstones were the 
most common abnormal hepatobiliary 
fi nding, they were not considered to en-
tirely account for the presenting symp-
toms in any patient. Both this study 
and another, which evaluated diagnostic 
tests in IBS (including US) ( 28 ), suggested 
that routine US was not necessary and 
may be counterproductive because of 
incidental fi ndings, which could lead 
to further diagnostic and therapeutic 
dilemmas, investigations, and interven-
tions, with potential for distress for the 
patient ( 28,32 ). No specifi c guidelines 
for CT, MR imaging, fl uoroscopy, or 
diarrhea-predominant symptoms un-
dergo colonoscopy with inspection of the 
distal ileum to exclude colon cancer and 
IBD [infl ammatory bowel disease], re-
spectively.” It was noted that lymphocytic 
or microcytic colitis (2.3% [fi ve of 216]) 
and nonspecifi c infl ammation (1.9% 
[four of 216]) only occurred in patients 
with diarrhea-predominant IBS, and 
hence it was recommended that colonos-
copy, when required, should include 
random colonic biopsies ( 27 ). There-
fore, according to these guidelines, 
colonic investigation of diarrhea-pre-
dominant IBS and mixed diarrhea and 
constipation–type IBS subgroups with 
barium enema or CT colonography is 
not appropriate because of inability to 
perform random biopsies. However, in 
patients with constipation-predominant 
IBS, the task force did not recommend 
any one colonic investigation over an-
other (colonoscopy, CT colonography, or 
barium studies) to exclude causes of 
mechanical obstruction ( 27 ). 
 SR-based guidelines addressed the 
use of colonic imaging, abdominal US, 
and CT in IBS ( 2 ). These guidelines sug-
gested performance of these investiga-
tions should be infl uenced by the likely 
underlying disease ( 2 ). The American 
College of Gastroenterology SR empha-
sized that physicians experienced in IBS 
are less likely to order diagnostic tests 
than physicians with less experience, 
many of whom view IBS as a diagno-
sis of exclusion ( 27,32 ). One primary 
literature article ( 28 ) reported that the 
positive predictive value of the Rome I 
criteria for the diagnosis of IBS in pa-
tients without concerning symptoms 
was 100% and 98%, in retrospective 
and prospective patient groups, respec-
tively. Nevertheless, 66% (41 of 62) of 
these patients with IBS younger than 
45 years who did not have concerning 
symptoms had at least a partial investi-
gation of the colon performed ( 28 ). 
 Another primary literature article 
( 31 ) concluded that further investiga-
tion of patients younger than 50 years 
who fulfi lled symptomatic criteria for 
IBS is not warranted on the basis of 
a retrospective review of 114 patients 
with IBS attending a gastroenterol-
ogy clinic with new symptoms, not 
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with IBS-type symptoms found that 
75% (1123 of 1497) fulfi lled the Rome II 
criteria and that 69.2% (1075 of 1553) 
underwent diagnostic investigations ( 42 ). 
Widespread imaging in patients with 
IBS-type symptoms possibly stems from 
a persisting perception that it con-
stitutes a diagnosis  of exclusion ( 43 ). 
Symptoms can mimic other conditions, 
and physicians often fear missing struc-
tural disease ( 17,44 ). These concerns 
can precipitate overinvestigation, in-
creased health care costs, exposure to 
ionizing radiation, and adverse events 
( 45 ). For example, 23.8% (7084 of 
29 710) of colonoscopies in the United 
States in patients younger than 50 years 
are for IBS symptoms ( 46 ). The perfo-
ration rate is 0.07% (343 of 491 311) for 
colonoscopy, 0.004 % (30 of 738 216) 
for barium enema, and 0.02% (one of 
5306) for CT colonography ( 47–49 ). 
 One SR demonstrated that the 
prevalence of structural disease in pa-
tients meeting symptom-based criteria 
for IBS was comparable with that of the 
general population ( 2 ). The exclusion 
of structural disease does not appear 
to be a valid justifi cation for indiscrim-
inate radiologic imaging in IBS. In the 
absence of worrisome symptoms, cur-
rent advice on colon cancer screening 
in patients with IBS should be no dif-
ferent than in the normal population 
( 50 ). It appears that early referral to a 
physician expert in IBS may be prefera-
ble to embarking on radiologic imaging, 
with a very low pretest probability of 
yielding structural disease. Physicians 
with expertise in IBS are less likely to 
order diagnostic tests than those with-
out such a background ( 51 ). A study 
community surveys in western Europe 
and North America suggest a prevalence 
of around 11.5% (4828 of 41 984) in the 
adult population ( 34 ). While many of 
those affected do not seek medical at-
tention and manage their symptoms by 
dietary changes and the use of a vari-
ety of remedies, a substantial minority 
have frequent and disabling symptoms 
that may incur a substantial effect on 
quality of life. Although the precise 
cause of IBS is not known, both psycho-
logic and emotional factors and chronic 
stress have been regarded as important 
precipitating factors in the induction of 
IBS symptoms. While, more recently, 
enteric infection, food intolerance, and 
immune activation and disturbances in 
the colonic and small intestinal micro-
fl ora have been proposed as playing a 
role in the pathophysiology of IBS ( 35 ), 
disordered intestinal motility and vis-
ceral hypersensitivity have long been 
regarded to be of primary importance 
( 36 ). However, the precise nature of 
the relationship between any one of 
these factors and the clinical presenta-
tion and/or natural history of IBS has 
yet to be elucidated. The diagnosis of 
IBS currently rests, therefore, on symp-
toms alone or, more precisely, on an 
aggregation of clinical symptoms. 
 Imaging in patients with IBS has 
serious implications for health care re-
sources; IBS accounts for 1.7–10 billion 
U.S. dollars in direct medical costs in 
the United States without substantial 
supportive evidence for their value 
( 11,37–41 ). A Canadian study of patients 
 Radiologic imaging in patients with 
IBS with symptoms concerning for 
underlying structural disease.— The 
American College of Gastroenterology 
review of the utility of symptoms of 
concern for the presence of underlying 
colorectal cancer diagnosis is summa-
rized in  Table 7 ( 27 ). There is evidence 
that patients presenting with IBS who 
have a family history of colorectal can-
cer, infl ammatory bowel disease, and 
celiac disease are at higher risk for 
structural disease ( 27 ). Overall, the 
American College of Gastroenterology 
suggested “that the accuracy of  alarm 
symptoms for identifying patients with 
underlying structural disease is disap-
pointing” ( 27 ). It also suggested that 
rectal bleeding and nocturnal pain of-
fer little discriminative value in sep-
arating patients with IBS from those 
with structural diseases and stated that 
“whereas anemia and weight loss have 
poor sensitivity for structural diseases, 
they offer good specifi city” ( 27 ). The 
American College of Gastroenterology 
concluded that “in patients who fulfi ll 
the symptom-based criteria of IBS, the 
absence of selected alarm features, 
including anemia, weight loss, and a 
family history of colorectal cancer, IBD 
[infl ammatory bowel disease] or celiac 
sprue, should re-assure physicians that 
the diagnosis of IBS is correct” ( 27 ). 
 Discussion 
 IBS is one of the most common disor-
ders encountered in modern medicine; 
 Table 6 
 Prevalence of Structural Disease in Patients Meeting Symptom-based Criteria for IBS 
Structural Gastrointestinal Disease
Prevalence among 
Patients with IBS (%)
Prevalence among General 
Population (%)
Colitis or infl ammatory bowel disease 0.51–0.98 0.3–1.2
Colorectal cancer 0–0.51 0–6
Gastrointestinal infection 0–1.7 5.1 (2695/52 840) * 
Lactose malabsorption 22–26 25
Celiac disease 4.7 0.25–0.5%
Note.—Data are derived from SR of six articles that included performance of 6619 diagnostic studies including colonoscopy, 
rectal biopsy, hematology profi le, thyroid function, biochemical test, fecal occult blood test, breath test, and US in patients with 
IBS ( 2 ).
* Data in parentheses are numbers used to calculate percentage. Prevalence of acute gastrointestinal illness in the general 
population was determined by Jones et al ( 33 ).
 Table 7 
 Utility of Symptoms of Concern to 






Rectal bleeding 64 (55, 73) 52 (42, 63)
Anemia 19 (5.5, 33) 90 (87, 92)
Weight loss 22 (14, 31) 89 (81, 95)
Source.—Reference  22 .
Note.—Data in parentheses are 95% confi dence intervals.
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the diagnostic yield of these investi-
gations. Ultimately, it would be of the 
most interest to know if radiologic im-
aging affects patient outcome. This can 
be best achieved in a prospective study 
that adheres to strict guidelines for the 
performance of specifi c imaging modal-
ities and then carefully follows clinical 
outcomes. Another approach could be 
a randomized control trial comparing 
the relative diagnostic yields with 
clinical effect of CT colonography and 
colonoscopy in a defi ned group of pa-
tients presenting with IBS-type symp-
toms. Outcomes such as cost, the 
frequency of clinically important ex-
tracolonic diagnoses, and the need for 
further optical colonoscopy could be as-
sessed. A major limitation of all such 
studies is the relative infrequency of al-
ternative diagnoses in subjects with IBS, 
in general ; study population numbers 
could be reduced by selecting subpop-
ulations with a likelihood of higher di-
agnostic yield, such as the elderly, for 
example. 
 The heterogeneity of the IBS co-
horts affects the strength of the arti-
cles we analyzed and, therefore, that 
of our fi ndings and conclusions. Some 
studies investigated diagnostic imaging 
in patients with IBS regardless of the 
presence or absence of symptoms of 
concern, whereas others only included 
patients with IBS with worrisome symp-
toms. There were additional potential 
limitations in the fi ve primary literature 
articles. Four articles examined 200 
patients with IBS or fewer, which rep-
resents a relatively small number and 
limits the recommendations that can 
be drawn ( 28,30–32 ). In addition, the 
IBS populations investigated did not 
always exclude patients who had al-
ready undergone diagnostic tests prior 
to referral to a specialist center. Thus, 
it is possible that some patients with 
IBS may have had structural disease 
already diagnosed or excluded prior to 
specialist referral, because those with 
abnormal biochemical or hematologic 
fi ndings were excluded ( 32 ). These fac-
tors represent a possible explanation 
for the large range (2% [seven of 306]–
23% [26 of 114]) in the prevalence of 
structural disease in the studies where 
be restricted to patients with typical 
meal-provoked symptoms, because pa-
tients with IBS with asymptomatic gall-
stones are in danger of being subjected 
to unnecessary cholecystectomy, with-
out benefi t to their pain ( 9 ). 
 With regard to the use of barium 
enema or CT colonography in IBS, 
there is little evidence in the litera-
ture. The American College of Gas-
troenterology guidelines suggest that 
where further investigation is required, 
diarrhea-predominant IBS and mixed 
diarrhea and constipation–type IBS 
should have colonoscopy supplemented 
by colonic biopsy, rather than barium 
enema or CT colonography ( 27 ). The 
additional yield of colonoscopy may still 
be limited even in these groups, given 
the results of a recent study of patients 
with nonconstipation IBS. It was found 
that there was no increased incidence 
of structural abnormalities in 466 pa-
tients with IBS and 451 control subjects 
after colonoscopy ( 54 ). The American 
College of Gastroenterology task force 
does not recommend any one colonic 
investigation in particular (colonoscopy, 
CT colonography, or barium studies) 
for the investigation of patients with 
constipation–type IBS to exclude me-
chanical obstruction ( 27 ). The Ameri-
can College of Radiology Appropriate-
ness guidelines for colorectal cancer 
screening would suggest, however, that 
CT colonography and double-contrast 
barium enema examination are not 
appropriate in high-risk patients, but 
that CT colonography is appropriate 
for middle- and low-risk patients and 
double-contrast barium enema should 
be considered when CT colonography 
is unavailable ( 50,53 ). It must also be 
conceded that the use of treatment 
failure as a criterion for further assess-
ment has not been studied in IBS and 
could well prove unhelpful given the 
poor record of available therapies in 
the management of IBS. 
 There are a number of potential 
methods of improving the evidence base 
relating to the use of radiologic imaging 
in IBS. As a starting point, a retrospec-
tive study could document factors that 
precipitate imaging in a well-defi ned co-
hort of patients with IBS and calculate 
of diagnostic costs in children with IBS 
found that pediatricians use imaging 
even less frequently than gastroen-
terologists ( 52 ). Gastroenterologists 
ordered abdominal US examinations, 
conventional radiography, and upper 
gastrointestinal series in 23.9% (11 
of 46), 4.4% (two of 46), and 17.4% 
(eight of 46) of patients, compared 
with 4.7% (two of 43), 14% (six of 43), 
and 0%, respectively, among pediatri-
cians. The cost of medical evaluation, 
including colonoscopy, but excluding 
upper gastrointestinal endoscopy, was 
fi ve times greater in children seen by a 
gastroenterologist than a pediatrician, 
even though there was no difference in 
symptoms between the groups. It was 
concluded that parent perception of the 
child’s symptoms could be the primary 
factor driving investigations ( 52 ). 
 The question of whether radiologic 
imaging is required for patients with IBS 
with symptoms that are potentially sug-
gestive of underlying structural disease 
is a complex one, because their pres-
ence may, on the one hand, be deemed 
suggestive of underlying structural 
disease but, on the other hand, they by 
no means exclude the diagnosis of IBS 
( 6 ). In patients with concerning symp-
toms, or in patients with IBS in whom 
initial treatment has failed to control 
symptoms, the choice of imaging mo-
dality should be infl uenced by likely un-
derlying disease. Therefore, we suggest 
that radiologic imaging in patients with 
IBS should be guided by the American 
College of Radiology Appropriateness 
Criteria (gastrointestinal imaging) and 
that the choice of imaging investigation 
should be infl uenced by the likely dif-
ferential diagnoses or typical symptom 
( 53 ). For example, in a patient with 
right upper quadrant pain with biliary 
features, American College of Radiol-
ogy Appropriateness Criteria recom-
mend abdominal US fi rst ( 53 ). Spiller 
suggests that only rarely should sphinc-
ter of Oddi dysfunction be considered, 
such as when pain is associated with 
a rise in liver enzymes or serum amy-
lase level ( 9,53 ). However, the referring 
physician should exert caution in the in-
terpretation of gallbladder US fi ndings 
in IBS, and these investigations should 
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